Device Use In Home Health Setting Surveyed As Part Of CDRH Strategic Plan
This article was originally published in The Gray Sheet
Executive Summary
FDA is conducting a rapid-response survey on home health care products to identify key issues associated with medical devices used in the home setting
You may also be interested in...
Regulatory News In Brief
Bird flu, special controls: Influenza A subtype tests and reagents are officially Class II medical devices following the March 22 release of a final rule and special controls 1guidance document detailing the 510(k) requirements for such products. The Centers for Disease Control & Prevention won clearance for the first rapid H5 subtype test to help identify avian flu cases through an expedited de novo 510(k) application in February (2"The Gray Sheet" Feb. 6, 2006, p. 11). Several firms are developing avian flu tests, including Toronto-based Tm Bioscience...
Regulatory News In Brief
Bird flu, special controls: Influenza A subtype tests and reagents are officially Class II medical devices following the March 22 release of a final rule and special controls 1guidance document detailing the 510(k) requirements for such products. The Centers for Disease Control & Prevention won clearance for the first rapid H5 subtype test to help identify avian flu cases through an expedited de novo 510(k) application in February (2"The Gray Sheet" Feb. 6, 2006, p. 11). Several firms are developing avian flu tests, including Toronto-based Tm Bioscience...
Home Healthcare Market Boom Expected, User-Friendly Devices Urged
As market growth in the home healthcare device industry is fueled by changing demographics and healthcare pressures, it will be increasingly important both from a public health and a marketing standpoint for manufacturers to engineer their products specifically for home use, panelists suggested at a recent FDLI meeting